Literature DB >> 20221647

Non-dysraphic intradural spinal cord lipoma: case series, literature review and guidelines for management.

Syed Mohammed Rezaul Kabir1, Dominic Thompson, Kia Rezajooi, Adrian T H Casey.   

Abstract

PURPOSE: Non-dysraphic intradural spinal cord lipomas are rare lesions and the management remains controversial. We present our experience with five cases and propose guidelines for their management.
METHODS: Five patients who underwent surgery for non-dysraphic spinal cord lipomas between January 2004 and April 2009 were retrospectively reviewed. All had varying degrees of neurological symptoms at the time of surgery with characteristic features on magnetic resonance imaging (MRI). All patients underwent decompression with a laminectomy/laminoplasty and debulking. The dura was primarily closed in one patient. The literature was also extensively reviewed regarding these rare lesions and optimum management guidelines proposed.
RESULTS: The age at presentation ranged from 17 to 52 years (mean 32.2). Minimum follow-up was 8 months and maximum follow-up was 5 years. There was neurological improvement following surgery in all cases. Post-operative MRI scan showed evidence of significant residual tumour in all patients.
CONCLUSION: The extent of surgical resection does not necessarily correlate with clinical outcome. The aim of surgery should, therefore, be adequate decompression with preservation of neural structures. Aggressive debulking should be avoided. Onset of any neurological symptoms/signs, bowel or bladder symptoms or intractable local symptoms should be an indication for surgery.

Entities:  

Mesh:

Year:  2010        PMID: 20221647     DOI: 10.1007/s00701-010-0620-y

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  1 in total

1.  Regrowth of Cervical Intradural Lipoma without Spinal Dysraphism.

Authors:  Doo Kyung Son; Dong Wuk Son; Chang Hwa Choi; Geun Sung Song
Journal:  J Korean Neurosurg Soc       Date:  2014-08-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.